FDA Clearance Tracker · P040050-S010
MACROPLASTIQUE IMPLANTS, MPQ-2.5
Last checked: Nov 20, 2026Latest source record: Dec 28, 2012 (this decision)Source: openFDAMethods & limitations
Decided
Dec 28, 2012
Approved
Time to decision
86 days
Received Oct 3, 2012. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P040050-S010
- Device name
- MACROPLASTIQUE IMPLANTS, MPQ-2.5
- Applicant
- Uroplasty, LLC
- Applicant location
- Minnetonka, MN
- Received
- Oct 3, 2012
- Decided
- Dec 28, 2012
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P040050
Device type
- Device class
- Class III
- Specialty
- GI, Urology & NephrologyUrology
FDA's approval statement
As written in FDA's record.
APPROVAL TO QUALIFY AN ALTERNATIVE SILICONE ELASTOMER MATERIAL FOR THE MACROPLASTIQUE SYRINGE STOPPER, AS WELL AS AN ALTERNATIVE SUPPLIER OF THE SYRINGE STOPPER (NUSIL TECHNOLOGY, LLC AT CARPINTERIA, CA.) THERE IS NO CHANGE TO THE INDICATIONS FOR USE OR LABELING OF THE MACROPLASTIQUE DEVICE.
Source documents
Other decisions for Uroplasty, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.